生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | BMS-202 is identified as a potent and nonpeptidic inhibitor of the PD-1/PD-L1 complex, demonstrating an IC50 of 18 nM and a KD of 8 μM. It binds to PD-L1, effectively preventing the interaction between human PD-1 and PD-L1, and exhibits antitumor capabilities[1].[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.38mL 0.48mL 0.24mL |
11.92mL 2.38mL 1.19mL |
23.84mL 4.77mL 2.38mL |
参考文献 |
---|